Welcome
Support Centre
20 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Exercise and vitamin C supplementation in type one diabetes mellitus
ISRCTN ISRCTN96164937
ClinicalTrials.gov identifier
Public title Exercise and vitamin C supplementation in type one diabetes mellitus
Scientific title Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type one diabetes mellitus: a randomised controlled trial
Acronym N/A
Serial number at source N/A
Study hypothesis Consistent with the human literature, we hypothesise that compared to healthy controls:
1. Exercise would compound basal oxidative stress in type one diabetics, and
2. Ascorbic acid would provide effective prophylaxis

A randomised, double-blind, placebo-controlled experimental design incorporating an electron paramagnetic resonance (EPR) spin-trapping technique combined with a comprehensive assessment of lipid peroxidation and non-enzymatic antioxidants will be employed to test these hypotheses.
Ethics approval Ethics approval received from The Bro Taf (Wales) Research Ethics Committee on the 18th December 1996 (ref: 96/1649).
Study design A balanced single-centre randomised double-blind placebo-controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Type one diabetes mellitus
Participants - inclusion criteria Diabetic volunteers were recruited from the adult diabetic clinic at the University Hospital of Wales, based on the following inclusion criteria:
1. Males aged 18 - 30 years
2. Glycosylated haemoglobin (HbA1c) of between 7 - 10%
3. Microalbuminuria negative
4. No underlying vascular complications

Non-diabetic control subjects were recruited from the student population of the University of Glamorgan, based on the following inclusion criteria:
1. Matched for age
2. Matched for fitness
3. No metabolic or circulatory medical condition
4. Had no family history of diabetes as confirmed via interview and medical history questionnaire
Participants - exclusion criteria 1. Cardiovascular disease
2. Hypertension
3. Any other known cardiac complication
Anticipated start date 01/01/2001
Anticipated end date 01/06/2001
Status of trial Completed
Patient information material
Target number of participants 12 male type one diabetic patients; 14 apparently healthy male volunteers
Interventions Subjects were randomised to receive:
1. 1 g ascorbic acid two hours prior to exercise
2. Placebo two hours prior to exercise

Supplementation took place once only for both treatment groups, and the follow up was conducted immediately post-exercise and 24 hours later via telephone.
Primary outcome measure(s) Free radical species in human blood, measured before supplementation, two hours after supplementation (before exercise) and immediately after exercise.
Secondary outcome measure(s) Blood biochemical markers such as lipid hydroperoxides, vitamin C and vitamin E, measured before supplementation, two hours after supplementation (before exercise) and immediately after exercise.
Sources of funding 1. University of Glamorgan (UK)
2. University Hospital of Wales (UK)
Trial website
Publications
Contact name Dr  Gareth  Davison
  Address University of Ulster
Jordanstown
Shore Road
  City/town Newtownabbey
  Zip/Postcode BT37 OQB
  Country United Kingdom
Sponsor University of Glamorgan (UK)
  Address Pontypridd
  City/town Cardiff
  Zip/Postcode CF37 1DL
  Country United Kingdom
  Sponsor website: http://www.glam.ac.uk/
Date applied 16/04/2008
Last edited 12/06/2008
Date ISRCTN assigned 12/06/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central